ICD-10-PCS Code Range for Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products

ICD-10-PCS Code Range for Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products is medical classification list by Centers for Medicare and Medicaid Services (CMS).

ICD-10-PCS code range (3E0), contains ICD-10-PCS codes for Circulatory, Administration, Physiological Systems and Anatomical Regions, Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products.

Subscribe to Codify and get the code details in a flash.

PCS Tables

3E0

3 Administration
E Physiological Systems and Anatomical Regions
0 Introduction: Putting in or on a therapeutic, diagnostic, nutritional, physiological, or prophylactic substance except blood or blood products
Body System / Region Approach Substance Qualifier
Character 4 Character 5 Character 6 Character 7
Body System (Character 4)
0 Skin and Mucous Membranes
Approach (Character 5)
X External
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
0 Skin and Mucous Membranes
Approach (Character 5)
X External
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
0 Skin and Mucous Membranes
Approach (Character 5)
X External
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
B Anesthetic Agent
K Other Diagnostic Substance
M Pigment
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
0 Skin and Mucous Membranes
Approach (Character 5)
X External
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
0 Open
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
A Anti-Infective Envelope
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
A Anti-Infective Envelope
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
4 Serum, Toxoid and Vaccine
Qualifier (Character 7)
0 Influenza Vaccine
Z No Qualifier
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
1 Subcutaneous Tissue
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
J Other Hormone
Body System (Character 4)
2 Muscle
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
2 Muscle
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
2 Muscle
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
2 Muscle
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
4 Serum, Toxoid and Vaccine
Qualifier (Character 7)
0 Influenza Vaccine
Z No Qualifier
Body System (Character 4)
2 Muscle
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
5 Other Antineoplastic
M Monoclonal Antibody
P Clofarabine
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
F Intracirculatory Anesthetic
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
P Platelet Inhibitor
R Antiarrhythmic
T Destructive Agent
X Vasopressor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
N Blood Brain Barrier Disruption
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
U Pancreatic Islet Cells
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
H Human B-type Natriuretic Peptide
J Other Hormone
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
0 Open
Substance (Character 6)
W Immunotherapeutic
Qualifier (Character 7)
K Immunostimulator
L Immunosuppressive
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
5 Other Antineoplastic
M Monoclonal Antibody
P Clofarabine
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
F Intracirculatory Anesthetic
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
P Platelet Inhibitor
R Antiarrhythmic
T Destructive Agent
X Vasopressor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
N Blood Brain Barrier Disruption
Q Glucarpidase
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
U Pancreatic Islet Cells
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
H Human B-type Natriuretic Peptide
J Other Hormone
Body System (Character 4)
3 Peripheral Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
W Immunotherapeutic
Qualifier (Character 7)
K Immunostimulator
L Immunosuppressive
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
5 Other Antineoplastic
M Monoclonal Antibody
P Clofarabine
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
F Intracirculatory Anesthetic
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
P Platelet Inhibitor
R Antiarrhythmic
T Destructive Agent
X Vasopressor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
N Blood Brain Barrier Disruption
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
H Human B-type Natriuretic Peptide
J Other Hormone
Body System (Character 4)
4 Central Vein
Approach (Character 5)
0 Open
Substance (Character 6)
W Immunotherapeutic
Qualifier (Character 7)
K Immunostimulator
L Immunosuppressive
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
5 Other Antineoplastic
M Monoclonal Antibody
P Clofarabine
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
F Intracirculatory Anesthetic
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
P Platelet Inhibitor
R Antiarrhythmic
T Destructive Agent
X Vasopressor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
N Blood Brain Barrier Disruption
Q Glucarpidase
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
H Human B-type Natriuretic Peptide
J Other Hormone
Body System (Character 4)
4 Central Vein
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
W Immunotherapeutic
Qualifier (Character 7)
K Immunostimulator
L Immunosuppressive
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
5 Other Antineoplastic
M Monoclonal Antibody
P Clofarabine
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
F Intracirculatory Anesthetic
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
P Platelet Inhibitor
R Antiarrhythmic
T Destructive Agent
X Vasopressor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
N Blood Brain Barrier Disruption
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
V Hormone
Qualifier (Character 7)
G Insulin
H Human B-type Natriuretic Peptide
J Other Hormone
Body System (Character 4)
5 Peripheral Artery
6 Central Artery
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
W Immunotherapeutic
Qualifier (Character 7)
K Immunostimulator
L Immunosuppressive
Body System (Character 4)
7 Coronary Artery
8 Heart
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
1 Thrombolytic
Qualifier (Character 7)
6 Recombinant Human-activated Protein C
7 Other Thrombolytic
Body System (Character 4)
7 Coronary Artery
8 Heart
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
7 Coronary Artery
8 Heart
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
K Other Diagnostic Substance
P Platelet Inhibitor
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
7 Coronary Artery
8 Heart
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
9 Nose
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
9 Nose
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
9 Nose
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
9 Nose
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
A Bone Marrow
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
A Bone Marrow
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
B Ear
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
B Ear
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
B Ear
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
3 Anti-inflammatory
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
B Ear
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
C Eye
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
C Eye
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
C Eye
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
3 Anti-inflammatory
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
M Pigment
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
C Eye
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
C Eye
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
D Mouth and Pharynx
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
D Mouth and Pharynx
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
D Mouth and Pharynx
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
3 Anti-inflammatory
4 Serum, Toxoid and Vaccine
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
R Antiarrhythmic
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
D Mouth and Pharynx
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
X External
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
E Products of Conception
G Upper GI
H Lower GI
K Genitourinary Tract
N Male Reproductive
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
S Gas
Qualifier (Character 7)
D Nitric Oxide
F Other Gas
Body System (Character 4)
F Respiratory Tract
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
3 Percutaneous
7 Via Natural or Artificial Opening
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
U Pancreatic Islet Cells
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
J Biliary and Pancreatic Tract
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
0 Open
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
5 Adhesion Barrier
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
L Pleural Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
0 Open
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Y Hyperthermic
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
5 Adhesion Barrier
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
M Peritoneal Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
0 Open
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
5 Adhesion Barrier
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
L Sperm
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
V Hormone
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
Q Fertilized Ovum
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
5 Adhesion Barrier
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
L Sperm
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
V Hormone
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
Q Fertilized Ovum
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
P Female Reproductive
Approach (Character 5)
8 Via Natural or Artificial Opening Endoscopic
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
A Stem Cells, Embryonic
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
E Stem Cells, Somatic
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
0 Open
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
Q Cranial Cavity and Brain
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
0 Open
Substance (Character 6)
A Stem Cells, Embryonic
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
0 Open
Substance (Character 6)
E Stem Cells, Somatic
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
A Stem Cells, Embryonic
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
E Stem Cells, Somatic
Qualifier (Character 7)
0 Autologous
1 Nonautologous
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
R Spinal Canal
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
S Epidural Space
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
2 High-dose Interleukin-2
3 Low-dose Interleukin-2
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
S Epidural Space
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
S Epidural Space
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
S Epidural Space
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
S Epidural Space
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
S Epidural Space
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
T Peripheral Nerves and Plexi
X Cranial Nerves
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
B Anesthetic Agent
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
T Peripheral Nerves and Plexi
X Cranial Nerves
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
U Joints
Approach (Character 5)
0 Open
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
U Joints
Approach (Character 5)
0 Open
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
B Recombinant Bone Morphogenetic Protein
Body System (Character 4)
U Joints
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
U Joints
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
U Joints
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
U Joints
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
B Recombinant Bone Morphogenetic Protein
C Other Substance
Body System (Character 4)
U Joints
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
U Joints
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
V Bones
Approach (Character 5)
0 Open
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
B Recombinant Bone Morphogenetic Protein
Body System (Character 4)
V Bones
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
V Bones
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
V Bones
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
V Bones
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
B Recombinant Bone Morphogenetic Protein
C Other Substance
Body System (Character 4)
W Lymphatics
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
W Lymphatics
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
W Lymphatics
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
W Lymphatics
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
2 Anti-infective
Qualifier (Character 7)
8 Oxazolidinones
9 Other Anti-infective
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
3 Anti-inflammatory
6 Nutritional Substance
7 Electrolytic and Water Balance Substance
B Anesthetic Agent
H Radioactive Substance
K Other Diagnostic Substance
N Analgesics, Hypnotics, Sedatives
T Destructive Agent
Qualifier (Character 7)
Z No Qualifier
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
3 Percutaneous
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
4 Percutaneous Endoscopic
Substance (Character 6)
G Other Therapeutic Substance
Qualifier (Character 7)
C Other Substance
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
0 Antineoplastic
Qualifier (Character 7)
4 Liquid Brachytherapy Radioisotope
5 Other Antineoplastic
M Monoclonal Antibody
Body System (Character 4)
Y Pericardial Cavity
Approach (Character 5)
7 Via Natural or Artificial Opening
Substance (Character 6)
S Gas
Qualifier (Character 7)
F Other Gas

December 31, 1969
Three new diagnosis codes for reporting COVID19 vaccination status will go into effect April 1 2022. The codes were presented by the National Center for Health Statistics NCHS at the Sept. 1415 ICD10 ... [ Read More ]
December 31, 1969
Latest Medicare rule changes aim to increase payment rates and improve health equity and quality of care for those with endstage renal disease. On Oct. 29 2021 The Centers for Medicare 38 Medicaid Ser... [ Read More ]
December 31, 1969
The 2022 MPFS final rule promotes greater telehealth utilization and boosts payment rates for vaccine administration. The Centers for Medicare 38 Medicaid Services CMS has finalized 2022 payments and ... [ Read More ]
December 31, 1969
HEALTHCON 2022 in Washington D.C. is coming quickly This will be yet another unforgettable event for medical billers coders and other healthcare business professionals. Come take in the sheer beauty o... [ Read More ]
December 31, 1969
The second and final day of AUDITCON AAPCs virtual conference dedicated to the world of auditing kicked off with attendees eager to learn more about the ins and outs of auditing. The chat wall was ful... [ Read More ]
resection of subclavian artery cpt?... [ Read More ]
Anybody have any idea when the January issue will be available online?... [ Read More ]
Hello, I am looking for the CPT codes for the following procedure to remove basal cell carcinoma. There is 1.5 cm ulceration on right cheek. Incision is mapped with 5 mm margin incorporating bil... [ Read More ]
Hello, Need assistance in verifying if the correct procedure performed was either 49329 or 49320, please review the below operative report. FINDINGS: Normal Right ovary visualized. Small part of La... [ Read More ]
PLEASE help with any remote coder positions available! I'm having the hardest time getting a full-time remote position as a coder, and I just graduated and got certified in June. Times are EXTREMELY... [ Read More ]
I am a Certified Professional Coder since 2017. I am also a foreign medical graduate. Each year I have been renewing my membership with AAPC and keep submitting 36 CEU. It is really frustrating for m... [ Read More ]
Hello! Please advise....not sure how to code for pap only visits to Medicaid. Our claim denied - service (99212 & 88164) not allowed for this DX (Z12.4). Thank you in advance!... [ Read More ]
Wondering if anyone can assist- I’m working for a clinic with several providers- many of whom have opted out of Medicare, meaning we are able to enter into a private contract with patients who would... [ Read More ]
Patient has elevated PSA (chronic stable) and also has a family history of prosate cancer. We are seeing him back in 6 months with repeat PSA. Is this a 99212 or can it somehow be a 99213 because of t... [ Read More ]
We seen a baby in our office yesterday and the child was critical. Can we bill a transfer code along with the 99291... [ Read More ]

Which Codify tool is right for you?

Call 844-334-2816 to speak with a Codify specialist now.